- Review
A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease
- Tadahiro Shoji,
- Hisashi Eto,
- Takanori Sato,
- Rikako Soma,
- Daisuke Fukagawa,
- Hidetoshi Tomabechi,
- Eriko Takatori,
- Takayuki Nagasawa,
- Seiya Sato and
- Masahiro Kagabu
- + 1 author
Treatment beyond progressive disease (PD) is a concept that even after drugs become ineffective, their continued use is more beneficial for patients than their discontinuation. In recent years, a concept of bevacizumab beyond PD (BBP) has attracted a...

